{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:52:01Z","timestamp":1789080721570,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T00:00:00Z","timestamp":1556755200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Institut de Recherche International Servier","award":["PHA-05682-097"],"award-info":[{"award-number":["PHA-05682-097"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ejvs.2018.02.009","type":"journal-article","created":{"date-parts":[[2018,3,24]],"date-time":"2018-03-24T19:54:52Z","timestamp":1521921292000},"page":"694-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Protective Effects of Micronized Purified Flavonoid Fraction (MPFF) on a Novel Experimental Model of Chronic Venous Hypertension"],"prefix":"10.1016","volume":"55","author":[{"given":"Maria","family":"das Gra\u00e7as C de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima ZGA","family":"Cyrino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge J","family":"de Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Blanc-Guillemaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliete","family":"Bouskela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejvs.2018.02.009_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1016\/j.ejvs.2015.02.007","article-title":"European society for vascular surgery. Editor's choice \u2013 management of chronic venous disease: clinical practice guidelines of the European society for vascular surgery (ESVS)","volume":"49","author":"Wittens","year":"2015","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0895-7967(02)70010-0","article-title":"The epidemiology, pathophysiology and natural history of chronic venous disease","volume":"15","author":"Tran","year":"2002","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib3","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/S0049-3848(09)70147-1","article-title":"Dermal pathology, cellular biology and inflammation in chronic venous disease","volume":"123","author":"Raffetto","year":"2009","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2174\/157016108784911957","article-title":"Matrix metalloproteinases in venous tissue remodeling and varicose vein formation","volume":"6","author":"Raffetto","year":"2008","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ejvs.2018.02.009_bib5","series-title":"Venous ulcers","first-page":"3","article-title":"Inflammation and the pathophysiology of chronic venous disease: molecular mechanisms","author":"Schmid-Sch\u00f6nbein","year":"2007"},{"key":"10.1016\/j.ejvs.2018.02.009_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2174\/1570161052773870","article-title":"Micronized purified flavonoid fraction (MPFF): a review of its pharmacological effects, therapeutic efficacy and benefits in the management of chronic venous insufficiency","volume":"3","author":"Katsenis","year":"2005","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.ejvs.2018.02.009_bib7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/jsre.1997.5189","article-title":"Elevated cutaneous leukocyte concentration in a rodent model of acute venous hypertension","volume":"74","author":"Lalka","year":"1998","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1006\/jsre.1998.5518","article-title":"Increased hind limb leukocyte concentration in a chronic rodent model of venous hypertension","volume":"81","author":"Hahn","year":"1999","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1006\/jsre.1999.5766","article-title":"Evaluation of the role of intercellular adhesion molecule 1 in a rodent model of chronic venous hypertension","volume":"88","author":"Hahn","year":"2000","journal-title":"J\u00a0Surg Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib10","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4103\/0253-7613.103260","article-title":"Influence of antioxidant complex on the adhesion of leukocytes in chronic venous insufficiency of lower limbs in rats","volume":"44","author":"Plotnikov","year":"2012","journal-title":"Indian J Pharmacol"},{"key":"10.1016\/j.ejvs.2018.02.009_bib11","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1177\/0003319701052001S06","article-title":"Therapeutic approach to chronic venous insufficiency and its complications: place of Daflon\u00ae 500 mg","volume":"52","author":"Bergan","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.ejvs.2018.02.009_bib12","first-page":"277","article-title":"Leukocyte involvement in the signs and symptoms of chronic venous disease. Perspectives for therapy","volume":"37","author":"Boisseau","year":"2007","journal-title":"Clin Hemorheol Microcirc"},{"key":"10.1016\/j.ejvs.2018.02.009_bib13","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1177\/000331970205300301","article-title":"Chronic venous insufficiency: worldwide results of the RELIEF study. Reflux assEssment and quaLity of lIfe improvEment with micronized Flavonoids","volume":"53","author":"Jantet","year":"2002","journal-title":"Angiology"},{"key":"10.1016\/j.ejvs.2018.02.009_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2165\/00003495-200363010-00005","article-title":"Micronized purified flavonoid fraction: a review of its use in chronic venous insufficiency, venous ulcers and haemorrhoids","volume":"63","author":"Lyseng-Williamson","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/j.ejvs.2018.02.009_bib15","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1177\/0003319703054001S05","article-title":"From symptoms to leg edema: efficacy of Daflon\u00ae 500 mg","volume":"54","author":"Nicolaides","year":"2003","journal-title":"Angiology"},{"key":"10.1016\/j.ejvs.2018.02.009_bib16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1053\/ejvs.1998.0751","article-title":"Endothelial activation response to oral micronized flavonoid therapy in patients with chronic venous disease\u2013a prospective study","volume":"17","author":"Shoab","year":"1999","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib17","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1067\/mva.2000.102724","article-title":"Effect of oral micronized purified flavonoid fraction treatment on leukocyte adhesion molecule expression in patients with chronic venous disease: a pilot study","volume":"31","author":"Shoab","year":"2000","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib18","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1159\/000054072","article-title":"Clinical efficacy of micronized purified flavonoid fraction: an overview","volume":"36","author":"Struckmann","year":"1999","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib19","series-title":"Guide for the care and use of laboratory animals","author":"National Research Council","year":"2011"},{"key":"10.1016\/j.ejvs.2018.02.009_bib20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1006\/mvre.2001.2324","article-title":"Effects of L-NA and sodium nitroprusside on ischemia\/reperfusion-induced leukocyte adhesion and macromolecular leakage in hamster cheek pouch venules","volume":"62","author":"Sim\u00f5es","year":"2001","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ejvs.2018.02.009_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.semvascsurg.2004.12.009","article-title":"Causes of severe chronic venous insufficiency","volume":"18","author":"Pappas","year":"2005","journal-title":"Semin Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s100169910092","article-title":"Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insufficiency","volume":"14","author":"Takase","year":"2000","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib23","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/jlb.55.5.662","article-title":"The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion","volume":"55","author":"Granger","year":"1994","journal-title":"J\u00a0Leukoc Biol"},{"key":"10.1016\/j.ejvs.2018.02.009_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0950-821X(05)80674-7","article-title":"The pathogenesis of skin damage in venous disease: a review","volume":"5","author":"Cheatle","year":"1991","journal-title":"Eur J Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib25","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1136\/bmj.285.6348.1071","article-title":"Pericapillary fibrin in the ulcer-bearing skin of the leg: the cause of lipodermatosclerosis and venous ulceration","volume":"285","author":"Burnand","year":"1982","journal-title":"Br Med J"},{"key":"10.1016\/j.ejvs.2018.02.009_bib26","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1177\/0003319701052001S04","article-title":"New advances in the understanding of the pathophysiology of chronic venous insufficiency","volume":"52","author":"Schmid-Sh\u00f6enbein","year":"2001","journal-title":"Angiology"},{"key":"10.1016\/j.ejvs.2018.02.009_bib27","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1161\/01.CIR.0000022846.22923.46","article-title":"Synthesis of collagen is dysregulated in cultured fibroblasts derived from skin of subjects with varicose veins as it is in venous smooth muscle cells","volume":"106","author":"Sansilvestri-Morel","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2018.02.009_bib28","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/0741-5214(92)90221-S","article-title":"In\u00a0vitro evaluation of endothelial and smooth muscle function of primary varicose veins","volume":"16","author":"Lowell","year":"1992","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib29","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.ejvs.2010.09.025","article-title":"Pharmacological treatment of primary chronic venous disease: rationale, results and unanswered questions","volume":"41","author":"Perrin","year":"2011","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.ejvs.2018.02.009_bib30","first-page":"81","article-title":"Different flavonoids present in the micronized purified flavonoid fraction (Daflon 500 mg) contribute to its anti-hyperpermeability effect in the hamster cheek pouch microcirculation","volume":"27","author":"Paysant","year":"2008","journal-title":"Int Angiol"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588418301060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588418301060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T11:48:06Z","timestamp":1761047286000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588418301060"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S1078588418301060"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2018.02.009","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective Effects of Micronized Purified Flavonoid Fraction (MPFF) on a Novel Experimental Model of Chronic Venous Hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2018.02.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society for Vascular Surgery. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}